Sun Pharmaceutical Industries today reported 75.17 per cent dip in its consolidated net profit at Rs 365.39 crore for the third quarter ended December 31, 2017-18.
The drug major had reported net profit of Rs 1,471.82 crore in the October-December quarter of 2016-17.
Its total revenue from operations stood at Rs 6,653.23 crore during the third quarter of 2017-18.
It was Rs 7,925.11 crore during the same period of previous fiscal.
Shares of the company today ended 2.53 per cent down at Rs 574.45 on the BSE.